izpis_h1_title_alt

Zolpidem improves task-specific dystonia : a randomized clinical trial integrating exploratory transcranial magnetic stimulation and [18F] FDG-PET imaging
ID Vogelnik Žakelj, Katarina (Avtor), ID Trošt, Maja (Avtor), ID Tomše, Petra (Avtor), ID Petrović, Igor N. (Avtor), ID Tomić Pešić, Aleksandra (Avtor), ID Radovanović, Saša (Avtor), ID Kojović, Maja (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (3,15 MB)
MD5: 5FC33E616DB4109A56B207E23B22C9AE
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S1353802024010265 Povezava se odpre v novem oknu

Izvleček
Background: Task-specific dystonia (TSFD) is a disabling movement disorder. Effective treatment options are currently limited. Zolpidem was reported to improve primary focal and generalized dystonia in a proportion of patients. The mechanisms underlying its therapeutic effects have not yet been investigated. Methods: We conducted a randomized, double-blind, placebo-controlled, crossover trial of single-dose zolpidem in 24 patients with TSFD. Patients were clinically assessed using Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS), Writers’ Cramp Rating Scale (WCRS), and Visual Analogue Scale (VAS), before and after receiving placebo and zolpidem. Transcranial magnetic stimulation was conducted on placebo and zolpidem to compare corticospinal excitability – active and resting motor thresholds (AMT and RMT), resting and active input/output curves and intracortical excitability - cortical silent period (CSP), short-interval intracortical inhibition curve (SICI), long-interval intracortical inhibition (LICI) and intracortical facilitation (ICF). Eight patients underwent brain FDG-PET imaging on zolpidem and placebo. Results: Zolpidem treatment improved TSFD. Zolpidem compared to placebo flattened rest and active input/output curves, reduced ICF and was associated with hypometabolism in the right cerebellum and hypermetabolism in the left inferior parietal lobule and left cingulum. Correlations were found between changes in dystonia severity on WCRS and changes in active input/output curve and in brain metabolism, respectively. Patients with lower RMT, and higher rest and active input/output curves exhibited better response to zolpidem compared to placebo. Conclusions: Zolpidem improved TSFD by reducing corticomotor output and influencing crucial nodes in higher-order sensory and motor networks.

Jezik:Angleški jezik
Ključne besede:zolpidem, writer's cramp, musician's dystonia, TMS, FDG-PET
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:9 str.
Številčenje:Vol. 124, art. 107014
PID:20.500.12556/RUL-158995 Povezava se odpre v novem oknu
UDK:616.8
ISSN pri članku:1353-8020
DOI:10.1016/j.parkreldis.2024.107014 Povezava se odpre v novem oknu
COBISS.SI-ID:199949571 Povezava se odpre v novem oknu
Datum objave v RUL:27.06.2024
Število ogledov:276
Število prenosov:52
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Parkinsonism & related disorders
Skrajšan naslov:Parkinsonism relat. disord.
Založnik:Elsevier
ISSN:1353-8020
COBISS.SI-ID:11416793 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-7310
Naslov:Novi ciljni receptorji pri distoniji: elektrofiziološki in slikovni korelati učinka zolpidema, selektivnega agonista benzodiazepinskega podtipa receptorja alfa-1, pri različnih oblikah primarne žariščne distonije

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj